Regulation of Fracture Repair by Growth Factors

Abstract

Fractured bones heal by a cascade of cellular events in which mesenchymal cells respond to unknown regulators by proliferating, differentiating, and synthesizing extracellular matrix. Current concepts suggest that growth factors may regulate different steps in this cascade (10). Recent studies suggest regulatory roles for PDGF, aFGF, bFGF, and TGF-beta in the initiation and the development of the fracture callus. Fracture healing begins immediately following injury, when growth factors, including TGF-beta 1 and PDGF, are released into the fracture hematoma by platelets and inflammatory cells. TGF-beta 1 and FGF are synthesized by osteoblasts and chondrocytes throughout the healing process. TGF-beta 1 and PDGF appear to have an influence on the initiation of fracture repair and the formation of cartilage and intramembranous bone in the initiation of callus formation. Acidic FGF is synthesized by chondrocytes, chondrocyte precursors, and macrophages. It appears to stimulate the proliferation of immature chondrocytes or precursors, and indirectly regulates chondrocyte maturation and the expression of the cartilage matrix. Presumably, growth factors in the callus at later times regulate additional steps in repair of the bone after fracture. These studies suggest that growth factors are central regulators of cellular proliferation, differentiation, and extracellular matrix synthesis during fracture repair. Abnormal growth factor expression has been implicated as causing impaired or abnormal healing in other tissues, suggesting that altered growth factor expression also may be responsible for abnormal or delayed fracture repair. As a complete understanding of fracture-healing regulation evolves, we expect new insights into the etiology of abnormal or delayed fracture healing, and possibly new therapies for these difficult clinical problems.

Bone ingrowth on the surface of endosseous implants. Part 1: Mathematical model

“…The first kinetic term takes into account the secretion of s 1 by platelets (Bolander, 1992;Bostrom, 1998) that depends on the degree of activation. Platelet activation in turn is assumed to be fostered by the concentration of adsorbed proteins p and the own growth factor s 1 (Park et al, 2001).…”

The use of autologous platelet–leukocyte gels to enhance the healing process in surgery, a review

“…Attempts are being made to create bone substitutes, but technologies are being developed that improve bone healing by adding biologic materials, such as PLG, to stimulate osteogenesis and osteoconduction. In bone healing (i.e., callus formation), platelets act as an exogenous source of growth factors stimulating the activity of bone cells on the basis of a unique role in bone growth [41,42].…”

Periodontal regeneration in deep intrabony periodontal defect using hydroxyapatite particles with platelet rich fibrin membrane–a case report

“…It is both chemotactic and mitogenic for osteoblasts and stimulates osteoblast type I collagen synthesis, which is the primary extracellular component of the bone. 8 Growth factors act by binding to the transmembrane receptor molecules on the mammalian cells and induce cytoplasmic cascade reaction, which give rise to the transcription of mRNA and intracellular and extracellular protein release. 9 Thus, within the limits, this case report has shown that the use of PRF membrane resulted in a significant pocket depth reduction and clinical attachment level gain in much lesser time.…”